An update of "Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model"
- PMID: 23363553
- PMCID: PMC3568412
- DOI: 10.1186/1471-2334-13-54
An update of "Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model"
Abstract
Background: To update a cost-effectiveness analysis of rotavirus vaccination in the Netherlands previously published in 2011.
Methods: The rotavirus burden of disease and the indirect protection of older children and young adults (herd protection) were updated.
Results: When updated data was used, routine infant rotavirus vaccination in the Netherlands would potentially become an even more cost-effective strategy than previously estimated with the incremental cost per QALY at only €3,000-4,000. Break-even total vaccination costs were indicated at €92-122, depending on the applied threshold.
Conclusions: We concluded that the results on potentially favourable cost-effectiveness in the previous study remained valid, however, the new data suggested that previous results might represent an underestimation of the economic attractiveness of rotavirus vaccination.
Similar articles
-
Cost effectiveness of a pentavalent rotavirus vaccine in Oman.BMC Infect Dis. 2014 Jun 17;14:334. doi: 10.1186/1471-2334-14-334. BMC Infect Dis. 2014. PMID: 24941946 Free PMC article.
-
Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.BMC Public Health. 2011 Jun 10;11:462. doi: 10.1186/1471-2458-11-462. BMC Public Health. 2011. PMID: 21663620 Free PMC article.
-
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".Vaccine. 2010 Nov 3;28(47):7457-9. doi: 10.1016/j.vaccine.2010.08.060. Epub 2010 Sep 21. Vaccine. 2010. PMID: 20846529
-
Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S48-55. doi: 10.1097/01.inf.0000197566.47750.3d. Pediatr Infect Dis J. 2006. PMID: 16397429 Review.
-
Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.J Infect Dis. 2009 Nov 1;200 Suppl 1:S16-27. doi: 10.1086/605026. J Infect Dis. 2009. PMID: 19817595 Review.
Cited by
-
Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.PLoS One. 2017 Mar 1;12(3):e0172414. doi: 10.1371/journal.pone.0172414. eCollection 2017. PLoS One. 2017. PMID: 28249046 Free PMC article.
-
Economic evaluation of routine infant rotavirus immunisation program in Japan.Hum Vaccin Immunother. 2017 May 4;13(5):1115-1125. doi: 10.1080/21645515.2016.1245252. Epub 2016 Oct 20. Hum Vaccin Immunother. 2017. PMID: 27763810 Free PMC article.
-
Economics and financing of vaccines for diarrheal diseases.Hum Vaccin Immunother. 2014;10(6):1568-81. doi: 10.4161/hv.28885. Epub 2014 Apr 22. Hum Vaccin Immunother. 2014. PMID: 24755623 Free PMC article. Review.
-
Systematic review of the economic value of diarrheal vaccines.Hum Vaccin Immunother. 2014;10(6):1582-94. doi: 10.4161/hv.29352. Epub 2014 May 27. Hum Vaccin Immunother. 2014. PMID: 24861846 Free PMC article.
-
Dissecting the indirect effects caused by vaccines into the basic elements.Hum Vaccin Immunother. 2015;11(9):2142-57. doi: 10.1080/21645515.2015.1052196. Epub 2015 Jul 17. Hum Vaccin Immunother. 2015. PMID: 26186100 Free PMC article. Review.
References
-
- Bruijning-Verhagen P, de Waal W, Winkel L, Felderhof M, van Houten M, Thijsen S, Rotavirus related hospitalizations: Incidence and contribution to seasonal peaks in pediatric hospital admissions. Thessaloniki, Greece: Poster at ESPID-conference 2012; 2012.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical